Abstract
Nanoparticles have gained significant importance in the past two decades, due to their multifaceted
applications in the field of nanomedicine. As our ecosystems and habitats are changing due to global warming,
many new diseases are emerging continuously. Treating these costs a lot of money and mostly ends up in failure.
In addition, frequent use of antibiotics to control the emerging diseases has led the pathogens to develop resistance
to antibiotics. Hence, the nanoparticles are targeted to treat such diseases instead of the costly antibiotics. In
particular, the biosynthesized nanoparticles have received considerable attention due to their simple, eco-friendly
and promising activity. To highlight, microbial mediated nanoparticles have been found to possess higher activity
and thus have a promising role in antimicrobial therapy to fight against the emerging drug-resistant pathogens. In
this context, this review article is aimed at highlight the role of nanoparticles in the field of nanomedicine and
importance of actinobacteria in the nanoparticle synthesis and their need in antimicrobial therapy. This is a comprehensive
review, focusing on the potential of actinobacteria-mediated nanoparticles in the field of nanomedicine.
Keywords:
Nanomedicine, antimicrobial therapy, actinobacteria, MDR, nanoparticles, drug resistance.
[16]
Rajasekhar C, Kanchi S. Green Nanomaterials for Clean Environment Handb Ecomater. Cham: Springer International Publishing 2018; pp. 1-18.
[23]
Pandey S, Madhuree K, Satyendra PS, et al. Bioremediation via Nanoparticles: An Innovative Microbial Approach Handb Res Uncovering New Methods Ecosyst Manag through Bioremediation. IGI Global 2018; pp. 491-515.
[32]
Das VL, Thomas R, Varghese RT, Soniya E V, Mathew J, Radhakrishnan EK. Extracellular synthesis of silver nanoparticles by
the Bacillus strain CS 11 isolated from industrialized area. 3 Biotech 2014; 4(2): 121-26.
[39]
Ahmed MF, Feroz M. A Survey on Drug Dispensing Patterns by Drug Retailers in Bangladesh 2015.
[53]
Heinz E, Ejaz H, Bartholdson-Scott J, Wang N, Guanjaran S, Pickard D. Emergence of carbapenem, beta-lactamase inhibitor and cefoxitin resistant lineages from a background of ESBL-producing Klebsiella pneumoniae and K. quasipneumoniae highlights different evolutionary mechanisms. bioRxiv 2018.283291
[55]
Savic M, Årdal C. A grant framework as a push incentive to stimulate research and development of new antibiotics 2018; 46: 9-24.
[67]
Gobalakrishnan R, Sivasankar P, Sivakumar K. Marine actinobacteria: A concise account for young researchers 2018.
[74]
McSorley FR, Johnson JW, Wright GD. Natural products in antibiotic discovery antimicrob resist 21st century. Cham: Springer International Publishing 2018; pp. 533-62.
[79]
Ranjitha VR, Rai VR. Actinomycetes mediated synthesis of gold
nanoparticles from the culture supernatant of Streptomyces
griseoruber with special reference to catalytic activity. 3 Biotech 2017. 7: 299
[87]
Naitō M, Yokoyama T, Hosokawa K, Nogi K, Eds. Nanoparticle technology handbook. 3rd ed. Elsevier 2018.
[116]
Dagmar H, Kristyna C, Pavel K, Vojtech A, Rene K. Selenium nanoparticles and evaluation of their antimicrobial activity on bacterial isolates obtained from clinical specimens 2015.